Evidence map›Paper›PMID 40036532›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2025

Predictors of Bi-directional Transitions From Mild Cognitive Impairment in a Diverse Cohort.

Mitzi M Gonzales, Roman Fernandez, Sarah Kremen, Zaldy S Tan, Amy E Werry, Xueqiu Jian, John Hart, Donald Royall, Gladys Maestre, Sara Espinoza and 3 more

Abstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Diagnostic value of saccades in mild cognitive impairment: a community-based study.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mitzi M GonzalesDepartment of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.ORCID 0000-0002-8467-0938
Roman FernandezDepartment of Population Health Sciences, University of Texas Health Science Center, San Antonio, Texas, USA.
Sarah KremenDepartment of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Zaldy S TanDepartment of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Amy E WerryGlenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, Texas, USA.
Xueqiu JianGlenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, Texas, USA.
John HartDepartment of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Donald RoyallGlenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, Texas, USA.
Gladys MaestreDepartment of Neuroscience, University of Texas Rio Grande Valley School of Medicine, San Antonio, Texas, USA.
Sara EspinozaDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Sudha SeshadriGlenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, Texas, USA.
Jonathan GelfondDepartment of Population Health Sciences, University of Texas Health Science Center, San Antonio, Texas, USA.
Chen-Pin WangGlenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, Texas, USA.

Funding

South Texas Alzheimer's Disease Research CenterP30AG066546 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Mohamad Habes · 2021 to 2026
$24.0M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUM1TR004538 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ROBERT A CLARK, Kenneth M Hargreaves · 2023 to 2026
$22.3M
LONGITUDINAL STUDY OF MEXICAN AMERICAN ELDERLY HEALTHR01AG010939 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI MARKIDES, KYRIAKOS S · 1992 to 2022
$14.6M
San Antonio OAIC - Research Education Component (REC)P30AG044271 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Adam Salmon · 2015 to 2026
$14.1M
Rio Grande Valley Alzheimer's Resource Center for Minority Aging Research: Partnerships for ProgressP30AG059305 · NIA · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI Gladys E. Maestre · 2018 to 2026
$5.8M
Cerebral tau deposition and comorbid cerebrovascular disease across the Alzheimer's disease continuum in Mexican AmericansR01AG085571 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GONZALES, MITZI MICHELLE, HABES, MOHAMAD · 2024 to 2025
$5.7M
Characterizing Older Mexican (American) Participation in Activity Digitally, Reliably, and Ecologically with the CART Platform (COMPADRE CART): Implications for Cognition and ADRDR01AG077472 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Zachary Beattie, Mitzi Michelle Gonzales · 2022 to 2026
$3.8M
Targeting Biology of Aging Mechanisms Underlying Alzheimer's Disease Risk with MetforminR01AG089711 · NIA · CEDARS-SINAI MEDICAL CENTER · PI Sara Elyse Espinoza, Mitzi Michelle Gonzales · 2024 to 2026
$2.3M
Genetic risk for trajectories of cognitive decline and progression to dementia among Mexican Americans and non-Hispanic whitesR21AG075791 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JIAN, XUEQIU · 2022 to 2022
$440k
NCATS NIH HHS UM1 TR004538NIA NIH HHS P30 AG044271NIA NIH HHS P30 AG059305NIA NIH HHS P30 AG066546NIA NIH HHS R01 AG010939NIA NIH HHS R01 AG077472NIA NIH HHS R01 AG085571NIA NIH HHS R01 AG089711NIA NIH HHS R21 AG075791NIH HHS P30 AG066546NIH HHS R01 AG010939NIH HHS R01 AG077472NIH HHS R21 AG075791Texas Alzheimer's Research and Care Consortium 2018-28-81-JITexas Council on Alzheimer's Disease and Related Disorders
6 · The paper itself

Abstract

Trajectories following a diagnosis of mild cognitive impairment (MCI) are varied and may fluctuate over time. Among diverse ethnic and racial groups, social factors, medical comorbidities, and biases in assessment procedures may contribute to greater heterogeneity in the MCI diagnostic category and affect its prognostic significance for dementia. The study goal was to evaluate the frequency and variables associated with MCI transitions among non-Hispanic White (NHW) and Latinx older adults. Multistate Markov models characterized transitions across diagnostic states (cognitively unimpaired (CU), MCI, dementia) over ten years. Variables associated with transitions were assessed using hazard ratios (HR) and 95% confidence intervals (CIs). The study included 413 participants (58% female, mean age 72 ± 8, 52% Latinx ethnicity). Following an MCI diagnosis, the likelihood of converting to dementia versus reverting to CU were equally probable. Older age, NHW ethnicity, APOE ε4, diabetes, lower BMI, and higher neuropsychiatric symptoms associated with elevated risk for dementia conversion, whereas younger age and lower neuropsychiatric symptoms associated with CU reversion. Above other factors, higher baseline serum glial fibrillary acidic protein (HR = 1.762 (95% CI: 1.367-2.271)) and neurofilament light (HR = 1.467 (95% CI: 1.152-1.69)) associated with increased dementia risk. Trajectories following an MCI diagnosis were highly variable with lower dementia conversion rates among Latinx relative to NHW adults, highlighting the need for strong diverse representation in research to capture the range of exposures shaping risk and resilience for cognitive decline. Well-validated blood-based biomarkers are likely to be instrumental for further improving personalized dementia risk predictions.

Indexed as

Cognitive DysfunctionDementiaAgedAged, 80 and overBiomarkersCohort StudiesDisease ProgressionFemaleHispanic or LatinoHumansMaleMarkov ChainsNeuropsychological TestsRisk FactorsWhiteBiomarkersBlood-based biomarkersDementiaEthnicityHealth disparitiesLatinx

Identifiers

PMID40036532
PMCPMC12363215

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.